Brookfield Asset Management Raises $61 Billion in Capital

1 Mins read

Brookfield Asset Management has experienced a successful year of capital raising, totaling $61 billion, with $26 billion raised in the latest quarter. This brings them closer to their goal of reaching $150 billion in total capital.

Strong Third Quarter Fundraising

The asset manager reported an excellent third quarter in terms of fundraising, with $102 billion in uncalled fund commitments as of the end of September. This substantial amount is available for market opportunities, including $45 billion that is not currently earning fees but is expected to generate approximately $450 billion in fees annually once deployed. Additionally, Brookfield holds nearly $3 billion in cash and equivalents on its balance sheet.

Largest Private Infrastructure Debt Fund

Last week, Brookfield closed what they claim to be the world’s largest private infrastructure debt fund, raising more than $6 billion for their global infrastructure debt program. This follows the recent closing of their flagship global private equity program, Brookfield Capital Partners VI, which raised a total of $12 billion.

Positive Financial Results

Total net income for the quarter increased to $494 million, or 30 cents a share, compared to $395 million, or 24 cents a share, in the same period last year. Revenue also rose by 7.5% to reach $893 million.

Future Growth Outlook

Brookfield Asset Management, majority owned by Brookfield Corp., remains optimistic about the future. With fundraising momentum continuing into the final quarter of the year, they anticipate first closes for their second transition flagship fund and fifth real estate flagship fund. Furthermore, they expect to complete a contract to manage American Equity Investment Life’s insurance assets. All of these developments bring them closer to achieving their capital raising target of $150 billion.

Related posts

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

15 − 12 =